Mark Demitrack
Hoofd Techniek/Wetenschap/O&O bij TREVENA, INC.
Vermogen: 17 045 $ op 31-12-2024
Profiel
Mark A.
Demitrack is currently the Chief Medical Officer at Trevena, Inc. and a Member of the American College of Neuropsychopharmacology.
Previously, he served as the Medical Director-New Antidepressant Team at Lilly Research Laboratories.
From 2003 to 2017, he was the Chief Medical Officer & Vice President at Neuronetics, Inc. He also worked as the Vice President-Clinical Strategy at Roivant Sciences Ltd.
from 2017 to 2018 and as the Assistant Vice President-Global Medical Affairs at Wyeth Pharmaceuticals, Inc. Dr. Demitrack completed his undergraduate degree at The Trustees of Columbia University in The City of New York and obtained his doctorate from Robert Wood Johnson Medical School.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
TREVENA, INC.
1,32% | 08-10-2024 | 11 363 ( 1,32% ) | 17 045 $ | 31-12-2024 |
Laatste nieuws over Mark Demitrack
Actieve functies van Mark Demitrack
Bedrijven | Functie | Begin |
---|---|---|
TREVENA, INC. | Hoofd Techniek/Wetenschap/O&O | 21-05-2018 |
American College of Neuropsychopharmacology
![]() American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Corporate Officer/Principal | - |
Eerdere bekende functies van Mark Demitrack
Bedrijven | Functie | Einde |
---|---|---|
ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 01-05-2018 |
NEURONETICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2017 |
Wyeth Pharmaceuticals, Inc.
![]() Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Corporate Officer/Principal | - |
Lilly Research Laboratories
![]() Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Corporate Officer/Principal | - |
Opleiding van Mark Demitrack
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Robert Wood Johnson Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
NEURONETICS, INC. | Health Technology |
TREVENA, INC. | Health Technology |
ROIVANT SCIENCES LTD. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Lilly Research Laboratories
![]() Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
Wyeth Pharmaceuticals, Inc.
![]() Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |
American College of Neuropsychopharmacology
![]() American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Commercial Services |